secwatch / observer
8-K filed November 25, 2025, 6:59 PM ET ticker PHGE CIK 0001739174
regulatory confidence high sentiment negative materiality 0.70

BiomX reports FDA clinical hold continues; DMC recommends adjusted dosing for Phase 2b CF study

BiomX Inc.

item 8.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001213900-25-114833
form_type
8-K
ticker
PHGE
cik
0001739174
company_name
BiomX Inc.
filed_at
2025-11-25T23:59:59+00:00
discovered_at
2026-05-14T18:02:40.287912+00:00
generated_at
2026-05-16T16:58:59.193272+00:00
sec_items
["8.01"]
event_type
regulatory
sentiment
negative
materiality_score
0.7
calibrated_materiality_score
0.7
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001213900-25-114833
json_url
https://secwatch.observer/filing/0001213900-25-114833.json
markdown_url
https://secwatch.observer/filing/0001213900-25-114833.md
text_url
https://secwatch.observer/filing/0001213900-25-114833.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1739174/000121390025114833/0001213900-25-114833-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1739174/000121390025114833/ea0267116-8k_biomx.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Comparable filings

LESL

Leslie's regains Nasdaq compliance for minimum market value of publicly held shares

Leslie's, Inc. June 1, 2026, 4:28 PM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

VYGR

FDA clears IND for VY1706, Voyager's tau-silencing gene therapy for Alzheimer's

Voyager Therapeutics, Inc. June 1, 2026, 8:00 AM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

EXFY

Expensify regains Nasdaq minimum bid price compliance

Expensify, Inc. May 29, 2026, 5:15 PM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

SLXN

Silexion Therapeutics completes 1-for-10 reverse share split; warrants adjusted

Silexion Therapeutics Corp May 29, 2026, 7:00 AM ET regulatory Items 3.03, 5.03, 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

RR

Richtech Robotics receives Nasdaq delisting notice for late Q1 10-Q filing

RICHTECH ROBOTICS INC. May 28, 2026, 4:49 PM ET regulatory Items 3.01, 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

MNKD

FDA releases MannKind from Afrezza malignancy study; sBLA for children PDUFA May 29

MANNKIND CORP May 28, 2026, 8:37 AM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

SNAL

Snail receives Nasdaq extension to Sept 22, 2026 to regain listing compliance

Snail, Inc. May 27, 2026, 4:25 PM ET regulatory Items 8.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

JAGX

Jaguar Health regains Nasdaq Bid Price compliance; monitoring until May 2027

Jaguar Health, Inc. May 27, 2026, 9:10 AM ET regulatory Items 7.01, 8.01, 9.01

same SEC item: 8.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001213900-25-114833
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.